SkinGen International’s group of companies is the result of a late 2015 amalgamation of talented,experienced management, proprietary technologies and products, sales and distribution networks, and revenue generating contracts.
SkinGen combines the management and assets of BASIS Medical Technologies Inc, based in Toronto, Canada, with SILDERM Limited, with offices in London and Congleton, UK, and select assets of AIME Medical Inc., based in Largo, USA. Combined, the executive team of SkinGen have over 80 years of experience in this medical sector.
SkinGen International is dedicated to developing a novel, safe, yet highly effective portfolio of products that target common dermatologic conditions. Advances in regenerative medicine create high value opportunities for products that focus on rosacea, seborrheic dermatitis, acne, pigmentation, hair/lash/brow growth, and post-procedural wound care.
SkinGen International has aligned itself with leading researchers in the field who are applying ingenuity to fashion new, advanced science-based platforms and products…PURE SKINGENUITY®.